Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-13

Clinical Trial Update: Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bromocriptine quick release as an adjunct therapy in type 1 diabetes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromocriptine Quick Release (bromocriptine)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2021-09-13